| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/14/2007 | US20070134258 Gasp1: a follistatin domain containing protein |
| 06/14/2007 | US20070134253 Serpentine transmembrane epithelial antigens of the prostate; polynucleotides, recombinant expression vectors, and host cells; anticarcinogenic agents; diagnosis and prognosis of urogenital and bone cancers and lymphomas |
| 06/14/2007 | US20070134250 Composition Comprising and Method of Using Angiopoietin-Like Protein 3 ANGPTL3 |
| 06/14/2007 | US20070134239 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 06/14/2007 | US20070134238 Modulation of T Cell Differentiation for the Treatment of T Helper Cell Mediated Diseases |
| 06/14/2007 | US20070134237 Human cytokine receptor |
| 06/14/2007 | US20070134221 Stabilizing peptides |
| 06/14/2007 | US20070134217 Using transposon vector as gene transfer and amplification tool; gene therapy |
| 06/14/2007 | US20070134206 Targeting proteins to deliver therapeutic or diagnostic reagents |
| 06/14/2007 | US20070134202 Cancer gene therapeutic drug |
| 06/14/2007 | US20070134201 Archaeon expression system |
| 06/14/2007 | US20070134197 Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
| 06/14/2007 | DE102005059242A1 Molekulare Marker für eine Tumordiagnose und -therapie Molecular markers for tumor diagnosis and therapy |
| 06/14/2007 | CA2826960A1 Targeting vector-phospholipid conjugates |
| 06/14/2007 | CA2639074A1 Marked bovine viral diarrhea virus vaccines |
| 06/14/2007 | CA2633161A1 Methods and compositions for expanding t regulatory cells |
| 06/14/2007 | CA2632723A1 Nucleic acids and methods for producing seeds having a full diploid complement of the maternal genome in the embryo |
| 06/14/2007 | CA2632708A1 Novel peptides and the biological use thereof |
| 06/14/2007 | CA2632682A1 In vivo cell surface engineering |
| 06/14/2007 | CA2632663A1 Immunostimulatory compositions and methods |
| 06/14/2007 | CA2632662A1 Methods of in vitro propagation and detection of infectious prion |
| 06/14/2007 | CA2632419A1 Genetically recombinant anti-perp antibody |
| 06/14/2007 | CA2632402A1 Treatment of epstein-barr virus-associated diseases |
| 06/14/2007 | CA2632269A1 Cys-rich, cell surface glycoproteins |
| 06/14/2007 | CA2631981A1 Methods and compositions for needleless delivery of binding partners |
| 06/14/2007 | CA2631785A1 Methods for generating antigen-specific effector t cells |
| 06/14/2007 | CA2631706A1 Methods of identifying agents that modulate mitochondrial function |
| 06/14/2007 | CA2631430A1 Polypeptides |
| 06/14/2007 | CA2630904A1 Compositions and methods for therapy and diagnosis of cancer |
| 06/14/2007 | CA2628614A1 Process for the preparation of ferri-succinylcasein |
| 06/14/2007 | CA2625978A1 Method for purifying fsh or a fsh mutant |
| 06/13/2007 | EP1795604A1 Telomelysin-gfp gene-containing recombinant virus |
| 06/13/2007 | EP1795600A2 Cell cycle stress-realted proteins and methods of use in plants |
| 06/13/2007 | EP1795599A1 Methods for generating antigen-specific effector T cells |
| 06/13/2007 | EP1795598A1 Novel peptides |
| 06/13/2007 | EP1795597A2 Nucleic acids isolated in neuroblastoma |
| 06/13/2007 | EP1795596A1 Composition and methods for therapy and diagnosis of cancer |
| 06/13/2007 | EP1795595A1 Gene specifically expressed in postmitotic dopaminergic neuron precursor cells |
| 06/13/2007 | EP1795540A1 Multimeric complexes of antigens and an adjuvant |
| 06/13/2007 | EP1795539A1 Cell penetrating peptides for intracellular delivery of molecules |
| 06/13/2007 | EP1795538A1 Peptides for inducing apoptosis in tumor cells |
| 06/13/2007 | EP1795203A2 Fhit proteins and nucleic acids and methods based thereon |
| 06/13/2007 | EP1794591A2 Process for removing endogenous vitamin b12 and folate from albumin preparations |
| 06/13/2007 | EP1794322A2 Klf6 alternative splice forms and a germline klf6 dna polymorphism associated with increased cancer risk |
| 06/13/2007 | EP1794308A2 Corn event das-59122-7 and methods for detection thereof |
| 06/13/2007 | EP1794304A2 Plant cells and plants with increased tolerance to environmental stress |
| 06/13/2007 | EP1794298A2 Production of mersacidin and its variants in sigh and/or mrsa negative bacillus host cells |
| 06/13/2007 | EP1794287A1 Use of il-17- for maturation of oocytes |
| 06/13/2007 | EP1794286A1 Use of pregnancy specific glycoprotein for maturation of oocytes |
| 06/13/2007 | EP1794190A2 Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
| 06/13/2007 | EP1794189A1 Ace-inhibitory whey hydrolysates |
| 06/13/2007 | EP1794188A1 Dna replication modulating peptides, nucleic acids encoding them, and their use in pharmaceutical compositions |
| 06/13/2007 | EP1794187A1 Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor |
| 06/13/2007 | EP1794186A2 Group a streptococcus crge protein |
| 06/13/2007 | EP1794185A1 Piscirickettsia salmonis antigens and use thereof |
| 06/13/2007 | EP1794184A2 Nucleic acid sequences encoding proteins associated with abiotic stress response and plant cells and plants with increased tolerance to environmental stress |
| 06/13/2007 | EP1794183A2 Hepatitis c virus replication system |
| 06/13/2007 | EP1793847A2 Use of microproteins as tryptase inhibitors |
| 06/13/2007 | EP1793841A1 Peptide inhibitors of c-jun dimerization and uses thereof |
| 06/13/2007 | EP1664308A4 Nucleotide sequences and polypeptides encoded thereby useful for increasing plant size and increasing the number and size of leaves |
| 06/13/2007 | EP1572897A4 Ordered biological nanostructures formed from chaperonin polypeptides |
| 06/13/2007 | EP1392814B1 Devices and methods for pharmacokinetic-based cell culture system |
| 06/13/2007 | EP1339737B1 Immunomodulatory protein derived from the yaba monkey tumor virus |
| 06/13/2007 | EP1309674B1 Stereoselective esterase from aspergillus oryzae |
| 06/13/2007 | EP1302542B1 Novel physiologically active peptide and use thereof |
| 06/13/2007 | EP1278850B1 Edg8 receptor, its preparation and use |
| 06/13/2007 | EP1244690B1 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent |
| 06/13/2007 | EP1235862B1 A major neutralization site of hepatitis e virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralization antibodies |
| 06/13/2007 | EP1230265B1 Ctage gene family |
| 06/13/2007 | EP1222250B1 Mutant lactic bacteria with a capacity for overexpressing at least one peptidase |
| 06/13/2007 | EP1220679B1 Cell-based gene therapy for the pulmonary system |
| 06/13/2007 | EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor |
| 06/13/2007 | EP1140969B1 Connective tissue growth factor fragments and methods and uses thereof |
| 06/13/2007 | EP1117804B1 Mutants of op-1 |
| 06/13/2007 | EP1100895B1 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 06/13/2007 | EP1071798B9 Constructs for controlled expression of recombinant proteins in prokaryotic cells |
| 06/13/2007 | EP1069909B1 Conjugate vaccines for the prevention of dental caries |
| 06/13/2007 | EP1037989B1 Nucleotide and protein sequence of mammastatin and methods of use |
| 06/13/2007 | EP1037909B1 Postweaning multisystemic wasting syndrome virus from pigs |
| 06/13/2007 | EP1027429B1 Jnk3 modulators and methods of use |
| 06/13/2007 | EP0986572B2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
| 06/13/2007 | EP0975354B1 Ligand/lytic peptide compositions and methods of use |
| 06/13/2007 | EP0954330B1 Intestinal trefoil proteins |
| 06/13/2007 | EP0948536B1 A g protein-coupled receptor with an enlarged extracellular domain |
| 06/13/2007 | EP0915909B1 Insecticidal protein toxins from xenorhabdus |
| 06/13/2007 | EP0914431B1 Truncated soluble tumor necrosis factor type-i receptors |
| 06/13/2007 | EP0876401B1 Methods for producing op-1 morphogen analogs |
| 06/13/2007 | EP0815136B1 Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
| 06/13/2007 | EP0792278B1 Tumor necrosis factor-gamma |
| 06/13/2007 | EP0788546B9 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 06/13/2007 | EP0742902B2 A method of assaying collagen fragments in body fluids, a test kit and means for carrying out the method and use of the method to diagnose the presence of disorders associated with the metabolism of collagen |
| 06/13/2007 | EP0680512B1 Immunogenic meningococcal lps and outer membrane vesicles and vaccine therefrom |
| 06/13/2007 | CN1981043A Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine |
| 06/13/2007 | CN1981033A Therapeutic, prophylactic and diagnostic agents for hepatitis b |
| 06/13/2007 | CN1981032A A novel strain of sars-associated coronavirus and use thereof |
| 06/13/2007 | CN1980955A Methods and compositions for enhancing cell adhesion properties |
| 06/13/2007 | CN1980954A Amylin family peptides and methods for making and using them |
| 06/13/2007 | CN1980953A Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 06/13/2007 | CN1980952A Multimerised HIV fusion inhibitors |
| 06/13/2007 | CN1980951A 抗微生物多肽 Antimicrobial peptides |